The Food and Drug Administration has approved the use of Avastin (bevacizumab) with chemotherapy to treat advanced cervical cancer – the first biologic to be authorised for this indication in combination with other agents. ---Subscribe to MedNous to access this article--- Company News Regulation & Policy
